Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O S Bruland

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Cancer therapy with radiolabeled antibodies. An overviewO S Bruland
Anticancer Research|November 4, 2000
Oral presentations in science and medicine. An art in decline?A Pihl, O S Bruland
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategyO S Bruland, A Pihl
British Journal of Cancer|May 6, 1998
Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delayR H Larsen, O S Bruland
Acta Oncologica (Stockholm, Sweden)|December 22, 1998
Radiotherapy in ScandinaviaD R Olsen, O S Bruland
Anticancer Research|July 1, 1989
Immunohistochemical detection of osteosarcoma-associated antigen in canine osteosarcomaD M Haines, O S Bruland
Physics in Medicine and Biology|April 28, 2001
Radionuclide therapy with bone-seeking compounds: Monte Carlo calculations of dose-volume histograms for bone marrow in trabecular boneY Kvinnsland, A Skretting, O S Bruland
Nuclear Medicine and Biology|April 1, 1997
212Bi-DOTMP: an alpha particle emitting bone-seeking agent for targeted radiotherapyS P Hassfjell, O S Bruland, P Hoff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 5, 2000
[Radiotherapy of skeletal metastases]M Braendengen, O S Bruland, D R Olsen
Nuclear Medicine and Biology|August 1, 1995
Cloning and sequencing of V genes from anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: location of lysine residues and implications for radiolabelingT Olafsen, O S Bruland, M R Zalutsky, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Cancer therapy with radiolabeled antibodies. An overviewO S Bruland
Anticancer Research|November 4, 2000
Oral presentations in science and medicine. An art in decline?A Pihl, O S Bruland
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategyO S Bruland, A Pihl
British Journal of Cancer|May 6, 1998
Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delayR H Larsen, O S Bruland
Acta Oncologica (Stockholm, Sweden)|December 22, 1998
Radiotherapy in ScandinaviaD R Olsen, O S Bruland
Anticancer Research|July 1, 1989
Immunohistochemical detection of osteosarcoma-associated antigen in canine osteosarcomaD M Haines, O S Bruland
Physics in Medicine and Biology|April 28, 2001
Radionuclide therapy with bone-seeking compounds: Monte Carlo calculations of dose-volume histograms for bone marrow in trabecular boneY Kvinnsland, A Skretting, O S Bruland
Nuclear Medicine and Biology|April 1, 1997
212Bi-DOTMP: an alpha particle emitting bone-seeking agent for targeted radiotherapyS P Hassfjell, O S Bruland, P Hoff
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 5, 2000
[Radiotherapy of skeletal metastases]M Braendengen, O S Bruland, D R Olsen
Nuclear Medicine and Biology|August 1, 1995
Cloning and sequencing of V genes from anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: location of lysine residues and implications for radiolabelingT Olafsen, O S Bruland, M R Zalutsky, et al.
Pageof 5